CXCR2 and ovarian cancer: High expression of CXCR2 or its ligand CXCL1 leads to increased ovarian cancer proliferation, which is believed to be partly mediated by transactivation of EGFR signaling, and the suppression of CXCR2 leads to apoptosis [16, 17].